Back to Directory
Britannia Pharmaceuticals
South East England
Founded 1982
Specialty pharmaceuticals for Parkinson's disease and related neurological conditions
Britannia Pharmaceuticals is a UK-based specialty pharmaceutical company developing and marketing treatments for Parkinson's disease and related conditions including psychosis.
The company's product range includes apomorphine-based therapies available in multiple delivery formats, alongside clozapine-based treatment for psychosis and mania.
Operating as part of an international pharmaceutical group across more than 30 countries, Britannia focuses on innovative solutions for chronic neurological and psychiatric conditions, supporting healthcare professionals and patients living with Parkinson's disease.